We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+6.19%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.7B
AUM Growth
+$2.52B
Cap. Flow
+$2.21B
Cap. Flow %
20.71%
Top 10 Hldgs %
17.42%
Holding
1,276
New
389
Increased
311
Reduced
230
Closed
325

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$119M
2
PRGO icon
Perrigo
PRGO
+$108M
3
MSFT icon
Microsoft
MSFT
+$107M
4
ZTS icon
Zoetis
ZTS
+$84.7M
5
VTRS icon
Viatris
VTRS
+$78.7M

Top Sells

Rank Stock Value
1
SHW icon
Sherwin-Williams
SHW
+$73.7M
2
JNJ icon
Johnson & Johnson
JNJ
+$67.8M
3
META icon
Meta Platforms (Facebook)
META
+$66.6M
4
NKE icon
Nike
NKE
+$57.9M
5
AZO icon
AutoZone
AZO
+$54.1M

Sector Composition

Rank Sector Weight
1 Healthcare 22.92%
2 Communication Services 13.85%
3 Financials 12.23%
4 Industrials 12.2%
5 Consumer Discretionary 11.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZTS icon
1
Zoetis
ZTS
$31.5B
$450M 4.22%
9,390,614
+1,874,617
+25% +$84.7M
TMUS icon
2
T-Mobile US
TMUS
$191B
$215M 2.02%
5,504,260
+1,226,819
+29% +$47.4M
BMY icon
3
Bristol-Myers Squibb
BMY
$128B
$195M 1.83%
2,833,753
+1,798,080
+174% +$119M
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$3.9T
$164M 1.54%
4,216,220
-1,359,700
-24% -$50.3M
CMCSA icon
5
Comcast
CMCSA
$79.6B
$163M 1.53%
5,771,286
+1,701,530
+42% +$51.2M
PFE icon
6
Pfizer
PFE
$140B
$159M 1.49%
5,183,129
+1,868,424
+56% +$58.8M
AGN
7
DELISTED
Allergan plc
AGN
$154M 1.44%
492,511
-156,326
-24% -$46.5M
LYB icon
8
LyondellBasell Industries
LYB
$19.7B
$130M 1.22%
1,495,654
+728,167
+95% +$67M
MSFT icon
9
Microsoft
MSFT
$2.85T
$115M 1.08%
2,067,247
+2,036,424
+6,607% +$107M
LBTYK icon
10
Liberty Global Class C
LBTYK
$3.23B
$112M 1.05%
3,174,031
+567,343
+22% +$20.5M
PRGO icon
11
Perrigo
PRGO
$1.4B
$103M 0.96%
708,384
+700,757
+9,188% +$108M
VTRS icon
12
Viatris
VTRS
$20.1B
$100M 0.94%
1,855,874
+1,636,790
+747% +$78.7M
C icon
13
Citigroup
C
$221B
$96M 0.9%
1,854,117
+613,683
+49% +$32.6M
GILD icon
14
Gilead Sciences
GILD
$162B
$87.4M 0.82%
864,092
-172,835
-17% -$18M
EL icon
15
Estee Lauder
EL
$29B
$81.4M 0.76%
924,800
+547,068
+145% +$46.6M
TWC
16
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$79.6M 0.75%
428,976
+138,869
+48% +$25.8M
SHW icon
17
Sherwin-Williams
SHW
$77.6B
$78.1M 0.73%
902,700
-851,904
-49% -$73.7M
MTG icon
18
MGIC Investment
MTG
$6.23B
$78M 0.73%
8,838,293
+2,760,757
+45% +$25.9M
AMZN icon
19
Amazon
AMZN
$2.5T
$75.4M 0.71%
2,231,740
+1,040,600
+87% +$32.8M
TEVA icon
20
Teva Pharmaceuticals
TEVA
$36B
$74.3M 0.7%
1,132,651
+1,080,061
+2,054% +$66.7M
RF icon
21
Regions Financial
RF
$26.1B
$73.6M 0.69%
7,665,179
+2,613,759
+52% +$25.1M
LAZ icon
22
Lazard
LAZ
$4.32B
$73.3M 0.69%
1,628,467
+156,202
+11% +$7.16M
CHTR icon
23
Charter Communications
CHTR
$14.8B
$72.3M 0.68%
394,682
-50,996
-11% -$9.44M
BCR
24
DELISTED
CR Bard Inc.
BCR
$71.1M 0.67%
375,232
+228,166
+155% +$42.7M
PARA
25
DELISTED
Paramount Global Class B
PARA
$70.7M 0.66%
1,499,973
+406,863
+37% +$19.1M
1
2 3 4 5

Similar funds

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Marshall Wace's Q4 2015 Portfolio in Review

As of Q4 2015, Marshall Wace held 1,276 positions worth $10.7B, up 31% from $8.14B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace deployed $2.21B of net new capital in Q4 2015, opening 389 new positions and adding to 311 existing holdings. Its largest new stake was The Mosaic Company: 1,613,517 shares worth $44.5M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was Sherwin-Williams, an estimated $73.7M trimmed.

  • Marshall Wace's largest Q4 2015 buy was The Mosaic Company: 1,613,517 shares worth $44.5M.
  • Marshall Wace added most to Bristol-Myers Squibb in Q4 2015, an estimated $119M increase.
  • Marshall Wace's biggest Q4 2015 reduction was Sherwin-Williams, cutting an estimated $73.7M.
  • Marshall Wace fully exited HOME PROPERTIES, INC in Q4 2015, selling an estimated $40.2M.
  • Marshall Wace's ten largest holdings make up 17% of its $10.7B portfolio in Q4 2015.
  • Marshall Wace opened 389 new positions and closed 325 in Q4 2015.
  • Marshall Wace's portfolio value rose 31% quarter-over-quarter to $10.7B.

Based on Marshall Wace's 13F filing for Q4 2015, filed 10 Feb 2016.